Frequent Optical Imaging during Breast Cancer Neoadjuvant Chemotherapy Reveals Dynamic Tumor Physiology in an Individual Patient

This publication has 43 references indexed in Scilit:

• Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative¹H MR Spectroscopy
  Radiology, 2009
• Residual Breast Cancer Diagnosed by MRI in Patients Receiving Neoadjuvant Chemotherapy with and Without Bevacizumab
  Annals of Surgical Oncology, 2009
• Converting evidence to practice: A guide for the clinical application of MRI for the screening and management of breast cancer
  European Journal Of Cancer, 2008
• In vivowater state measurements in breast cancer using broadband diffuse optical spectroscopy
  Physics in Medicine & Biology, 2008
• Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
  Clinical Cancer Research, 2008
• Assessing the spatial extent of breast tumor intrinsic optical contrast using ultrasound and diffuse optical spectroscopy
  Journal of Biomedical Optics, 2008
• Molecular Imaging Research in the Outcomes Era: Measuring Outcomes for Individualized Cancer Therapy
  Academic Radiology, 2007
• Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy
  Proceedings of the National Academy of Sciences, 2007
• Intrinsic tumor biomarkers revealed by novel double-differential spectroscopic analysis of near-infrared spectra
  Journal of Biomedical Optics, 2007
• Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast Cancer
  American Journal of Roentgenology, 2005